131 related articles for article (PubMed ID: 6350337)
1. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
Trischitta V; Gullo D; Pezzino V; Vigneri R
J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
[TBL] [Abstract][Full Text] [Related]
2. Metformin and insulin receptors.
Vigneri R; Gullo D; Pezzino V
Diabetes Care; 1984; 7 Suppl 1():113-7. PubMed ID: 6376023
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
[TBL] [Abstract][Full Text] [Related]
4. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.
Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R
Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888
[TBL] [Abstract][Full Text] [Related]
5. Insulin internalization into monocytes is decreased in patients with type II diabetes mellitus.
Trischitta V; Gullo D; Squatrito S; Pezzino V; Goldfine ID; Vigneri R
J Clin Endocrinol Metab; 1986 Mar; 62(3):522-8. PubMed ID: 3944236
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.
Fantus IG; Brosseau R
J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.
Lord JM; White SI; Bailey CJ; Atkins TW; Fletcher RF; Taylor KG
Br Med J (Clin Res Ed); 1983 Mar; 286(6368):830-1. PubMed ID: 6403102
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptors on monocytes and erythrocytes from obese patients.
De Pirro R; Fusco A; Lauro R; Testa I; Ferretti G; De Martinis C
J Clin Endocrinol Metab; 1980 Dec; 51(6):1437-9. PubMed ID: 7002953
[TBL] [Abstract][Full Text] [Related]
11. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
12. Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.
Vague P; Juhan-Vague I; Alessi MC; Badier C; Valadier J
Thromb Haemost; 1987 Jun; 57(3):326-8. PubMed ID: 3310318
[TBL] [Abstract][Full Text] [Related]
13. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients.
Trischitta V; Brunetti A; Chiavetta A; Benzi L; Papa V; Vigneri R
Diabetes; 1989 Dec; 38(12):1579-84. PubMed ID: 2684714
[TBL] [Abstract][Full Text] [Related]
14. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
Ozata M; Oktenli C; Bingol N; Ozdemir IC
Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.
Dandona P; Aljada A; Ghanim H; Mohanty P; Tripathy C; Hofmeyer D; Chaudhuri A
J Clin Endocrinol Metab; 2004 Oct; 89(10):5043-7. PubMed ID: 15472203
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
[TBL] [Abstract][Full Text] [Related]
17. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
18. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
Santos RF; Nomizo R; Bopsco A; Wajchenberg BL; Reaven GM; Azhar S
Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903
[TBL] [Abstract][Full Text] [Related]
19. Insulin binding to monocytes in obese patients treated with carbohydrate restriction and changes in physical activity.
Misbin RI; Moffa AM; Kappy MS
J Clin Endocrinol Metab; 1983 Feb; 56(2):273-8. PubMed ID: 6337175
[TBL] [Abstract][Full Text] [Related]
20. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.
Bar RS; Gorden P; Roth J; Kahn CR; De Meyts P
J Clin Invest; 1976 Nov; 58(5):1123-35. PubMed ID: 993336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
